MLF1 - N-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-MLF1 - N-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | MLF1 - N-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rabbit, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This is a rabbit polyclonal antibody against MLF1. It was validated on Western Blot using a cell lysate as a positive control.Target Description: MLF1 is involved in lineage commitment of primary hemopoietic progenitors by restricting erythroid formation and enhancing myeloid formation. It interferes with erythopoietin-induced erythroid terminal differentiation by preventing cells from exiting the cell cycle through suppression of CDKN1B/p27Kip1 levels. MLF1 suppresses RFWD2/COP1 activity via CSN3 which activates p53 and induces cell cycle arrest.It binds DNA and affects the expression of a number of genes so may function as a transcription factor in the nucleus. |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human MLF1 |
| Other Names | [myeloid leukemia factor 1 isoform 1; Myeloid leukemia factor 1; myeloid leukemia factor 1; myeloid leukemia factor 1; Myelodysplasia-myeloid leukemia factor 1] |
| Gene, Accession # | [MLF1], Gene ID: 4291, NCBI: NP_071888, UniProt: P58340 |
| Catalog # | MBS3211494 |
| Price | $335 |
| Order / More Info | MLF1 - N-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies